EUVIMEDEUVIMED entdecken
Open Access

Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximab

Masuho Saburi, Masanori Sakata, Yousuke Kodama, Keiichi Uraisami, Hiroyuki Takata, Yasuhiko Miyazaki, Junpei Wada, Shogo Urabe, Eiichi Ohtsuka

Journal of Clinical and Experimental Hematopathology · 2023

DOI: 10.3960/jslrt.23017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2023. Verfasst von Masuho Saburi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oita Prefectural Hospital, Oita, Japan. Hauptthemen laut MEDLINE: Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Non-HodgkinLymphoma, Large B-Cell, DiffuseHumansRituximabBendamustine HydrochlorideAntibodies, MonoclonalAntineoplastic Combined Chemotherapy ProtocolsImmunoconjugates

Stichwörter der Autor:innen

MYC translocationbendamustinediffuse large B-cell lymphomapolatuzumab vedotin

Substanzen

RituximabBendamustine HydrochlorideAntibodies, Monoclonalpolatuzumab vedotinImmunoconjugates

Autor:innen und Institutionen

  • Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
  • Department of Pathology, Oita Prefectural Hospital, Oita, Japan.

Zitieren

APA

Saburi, M., Sakata, M., Kodama, Y., Uraisami, K., Takata, H., Miyazaki, Y., Wada, J., Urabe, S., & Ohtsuka, E. (2023). Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximab. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.23017

Vancouver

Saburi M, Sakata M, Kodama Y, Uraisami K, Takata H, Miyazaki Y, et al. Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximab. Journal of Clinical and Experimental Hematopathology. 2023. doi:10.3960/jslrt.23017

BibTeX
@article{Saburi2023,
  author = {Saburi, Masuho and Sakata, Masanori and Kodama, Yousuke and Uraisami, Keiichi and Takata, Hiroyuki and Miyazaki, Yasuhiko and Wada, Junpei and Urabe, Shogo and Ohtsuka, Eiichi},
  title = {Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximab},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2023},
  doi = {10.3960/jslrt.23017}
}
Kostenlos starten →